CN107625894A - A kind of preparation method of compound ginseng stilbene dispersible tablet - Google Patents

A kind of preparation method of compound ginseng stilbene dispersible tablet Download PDF

Info

Publication number
CN107625894A
CN107625894A CN201710944041.XA CN201710944041A CN107625894A CN 107625894 A CN107625894 A CN 107625894A CN 201710944041 A CN201710944041 A CN 201710944041A CN 107625894 A CN107625894 A CN 107625894A
Authority
CN
China
Prior art keywords
premix
powder
stilbene
dispersible tablet
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710944041.XA
Other languages
Chinese (zh)
Inventor
王晓林
钟方丽
王慧竹
薛健飞
陈帅
杨艳俊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jilin Institute of Chemical Technology
Original Assignee
Jilin Institute of Chemical Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jilin Institute of Chemical Technology filed Critical Jilin Institute of Chemical Technology
Priority to CN201710944041.XA priority Critical patent/CN107625894A/en
Publication of CN107625894A publication Critical patent/CN107625894A/en
Pending legal-status Critical Current

Links

Abstract

The invention provides a kind of preparation method of compound ginseng stilbene dispersible tablet, including ginseng, the Radix Astragali, cassia seed, prepared rhizome of rehmannia, rhizoma Gastrodiae, the taste Chinese medicine of rhizoma alismatis 6 to join stilbene dry extract powder through compound made from water extract-alcohol precipitation, vacuum drying;Stilbene dry extract powder and kushenin are joined using compound and prepare compound ginseng stilbene dispersible tablet as raw material.The present invention creatively uses method of the Stepanol MG as surfactant assisted extraction in extraction step;The premix of pregelatinized starch, three kinds of microcrystalline cellulose, lactose auxiliary materials is creatively selected to join the diluent of stilbene dispersible tablet as compound;Creatively from PVPP, two kinds of auxiliary materials of low-substituted hydroxypropyl cellulose premix as compound join stilbene dispersible tablet disintegrant;Creatively join the lubricant of stilbene dispersible tablet as compound from the premix powder of superfine silica gel powder and Macrogol 4000;Flavouring protein sugar powder has creatively been dissolved in the ethanol solution of PVP K30.

Description

A kind of preparation method of compound ginseng stilbene dispersible tablet
Technical field
The present invention relates to pharmaceutical technology field, and in particular to a kind of preparation method of compound ginseng stilbene dispersible tablet.
Background technology
Modern pharmacological research reports that ginseng can increase the nonspecific resistance of body, to various adverse factors, such as physics , chemical, biological harmful effect can increase the resistance of body;Ginseng can significantly extend mouse swimming it is lasting when Between, the death rate of the mouse under high temperature, low temperature, low pressure state can be significantly reduced, has and promotes dog to be got well from critically ill state Effect;Ginseng still has the function that to strengthen immunologic function.In addition ginseng also has the sedation of central nervous system;Also The effect of similar cardiac glycoside;Promote the effect of adrenal cortex function;Hypoglycemic effect;The content rise of hematopoietin Effect etc., ginseng can promote the division of myeloid element, make the content of leucocyte in peripheral blood, red blood cell and hemoglobin Increase, improve the immunologic function of the elderly, strengthen body antiserum shock, mitigate the fatigue and hypomnesia of the elderly.
Modern pharmacological research reports that the Radix Astragali can stimulate myelosis, improve the secretion of Hemopoietic factor;The Radix Astragali also has enhancing Immunologic function, extend the effect of cell body survival;Astragalus polyose can dramatically increase the phagocytosis of mouse macrophage;Improve empty Spot forms haematolysis ability and the effect of obvious carbon particle clearance of cell;There is obvious antitumor, anti-aging;It can strengthen Mouse is acted on the memory of study and consolidating memory, and has stronger diuresis;There is antivirus action etc..The single Radix Astragali can make The lymphocyte transformation rate of immunologic hypofunction mouse rises, and IL22 can also be induced to produce when dosage is appropriate.In addition, the Radix Astragali is in body Inside also there is the partial function for promoting Th1 and Th2 cells, so as to improve the jejune immune state of body.The Radix Astragali can promote carefully The increase of intracellular CAMP contents, so as to promote the synthesis of bone marrow cell DNA and protein, accelerate point of karyocyte Split.
Kushenin is the mixed base of oxymatrine and very small amount N-Oxysophocarpine, and modern pharmacological research shows that kushenin has Numerous pharmacological actions:It is such as antiviral;Induce endogenous interferon;Liver cell is protected, improves liver function;Anti-hepatic fibrosis;Rise Leucocyte;It is antitumor etc..
Rhizoma Gastrodiae has humidification to the cellular immunity in mouse nospecific immunity and specific immunity and humoral immunity, In addition still there is obvious analgesic activity etc..
Prepared rhizome of rehmannia water extraction liquid energy dramatically increases peripheral blood in mice T lymphocytes.
Rhizoma alismatis plays the role of diuresis, reducing blood lipid, anti-fatty liver, increase coronary flow, reduction blood glucose;Rhizoma alismatis has stronger Anti-malignant tumor transferance.
Cassia seed has inhibitory action to immune function of mice, can strengthen the phagocytic function of macrophage.
This product is the principle prescription treatinged deficiency with tonification according to traditional Chinese medicine, and ginseng, the Radix Astragali reinforce vital energy in side, qi and blood can be promoted to give birth to Changing, improve the immunity of body, people participates in the Radix Astragali and shares its tonifying Qi effect more preferably, replenished qi to invigorate the spleen with reaching, regulating yin and yang, entangle Positive negative and positive, the pathological phenomenon contained, declined partially partially, recover or improve the function of internal organs;Prepared rhizome of rehmannia Zishen fill fine;Rhizoma alismatis diuresis is without hindering Sun.This product, which has reached the traditional Chinese medical science, which strengthens the body resistance to consolidate the constitution, strengthens the purpose of resistance against diseases, while compensate for simple western medicine in the treatment and treat it Deficiency, embody the advantage of the combination of Chinese tradiational and Western medicine.
The treatment of cancer is based on Radiotherapy chemotherapy, in order to improve the survival rate of cancer patient and reduce DISTANT METASTASES IN, Radiotherapy chemotherapy Complex treatment is currently to III phase, the primary treatment scheme of IV a phase cancers.But during Radiotherapy chemotherapy, bone marrow suppression is most normal The side effect seen, it not only influences complex treatment and is smoothed out but also the raising that affects the treatment.After cancer radiation starts, the radiotherapy time It is close with therapeutic effect relationship, stop one week, curative effect declines 10%~15%, so ensureing that smoothly completing for radiotherapy is particularly significant.Otherwise, Radiotherapy effect can be had a strong impact on.At present, can cause in most of antineoplastics and the chemotherapy process of tumour different degrees of Bone marrow suppression, be that many tumor patients can not smoothly complete chemotherapy cycles, even result in interrupt treatment one of major reason this Often lead to treatment to interrupt, directly affects effect of the chemotherapeutics to oncotherapy.Cancer patient is in chemotherapy with chemotherapeutic Thing cumulant increase in vivo, its side reaction are mainly shown as that bone marrow suppression, gastrointestinal dysfunction, immunologic function reduce.Therefrom Doctor's angle says predominantly qi and blood damage, taste imbalance, liver-kidney deficiency, therefore in treating based on righting help, i.e. benefiting qi and nourishing blood, strong Spleen and stomach, nourishing kidney essence.Benefiting qi for promoting production of blood medicine can strengthen immunologic function, improve body resistance against diseases, promote the conjunction of RNA and protein Into having certain stimulation to hemopoietic system to embody its function.Kidney-nourishing tcm drug, which also has, promotes hematopoietic cell proliferation effect, also shadow Marrow stromal cell is rung, experiment proves that recovery of the nourishing kidney essence to bone marrow suppression has positive role.Due to tumour cell and just Lack the metabolic disorder of essence between normal cell, therefore most of cancer therapy drugs can not still be kept away while tumour cell is killed Exempt from the infringement to normal cell, it is bigger especially to breed the infringement that faster haemocyte is subject to, so as caused by chemotherapeutics Marrow hemopoiesis suppresses the serious dosage and frequency for limiting chemotherapy, influences being smoothed out and restricting its therapeutic effect for chemotherapy.Cause This, in the market very demand curative effect is high, price is honest and clean, Small side effects raising immunity of organisms, the medicine of increasing leukocyte.
Dispersible tablet is a kind of solid pharmaceutical preparation, both orally available, is also dispersible in water and is taken as solution, especially to swallowing Difficult children and old man are more convenient.Dispersible tablet have convenient oral, disintegration time are short, be uniformly dispersed, drug-eluting is rapid, Absorb the advantages that fast, bioavilability is high, adverse reaction is small.
The content of the invention
In view of this, it is an object of the invention to provide a kind of preparation method of compound ginseng stilbene dispersible tablet, including following step Suddenly:
1)To ginseng, the Radix Astragali, cassia seed, prepared rhizome of rehmannia, rhizoma Gastrodiae, the taste Chinese medicine of rhizoma alismatis 6 in the presence of surfactants through water extracting alcohol It is heavy to obtain extraction immersion liquid, obtain compound ginseng stilbene dry extract powder by being dried in vacuo;
2)Stilbene dry extract powder and kushenin powder are joined as raw material using compound, add the premix of diluent, partial disintegration agent Premix, pelletized by adhesive of the ethanol solution of PVP K30;
3)The dry particl of compound ginseng stilbene dispersible tablet is well mixed with partial disintegration agent premix and lubricant premix, tabletting, Prepare compound ginseng stilbene dispersible tablet.
Preferably, in the preparation method of compound ginseng stilbene dispersible tablet of the present invention, the step 1)In 6 taste Chinese medicines carry Take, carry out by the following method:Weigh ginseng 380g, Radix Astragali 310g, cassia seed 180g, prepared rhizome of rehmannia 180g, rhizoma Gastrodiae 90g, rhizoma alismatis 130g is placed in extractor, is added 3.81g surfactants and is added the Extraction solvent of 10 times of crude drug amounts, extraction 2 times, every time 2h, filtering, merging filtrate, filtrate decompression are concentrated into relative density as 1.20~1.25(60~65 DEG C)Clear cream, add ethanol to make Alcohol content stands 24h, filtering, filtrate decompression concentration and recovery ethanol, is concentrated into relative density as 1.20~1.25 up to 70%(60~ 65℃)Clear cream, be dried in vacuo into dry extract, above-mentioned dry extract crushed, cross 80~100 mesh sieves, obtain the dry leaching of compound ginseng stilbene Cream powder;It is highly preferred that the Extraction solvent is water, refluxing extraction number is 2 times, and each extraction time is respectively 2,2h;More Preferably, surfactant is Stepanol MG, and its dosage is the 0.3% of 6 taste Chinese medicine gross masses.
Preferably, in the preparation method of compound ginseng stilbene dispersible tablet of the present invention, the step 2)Middle compound ginseng stilbene disperses The method of granulating of piece is wet granulation.
It is highly preferred that the step 2)Middle pelletization is as follows:By kushenin, diluents microcrystalline cellulose, pregelatinated form sediment Powder, lactose, disintegrant PVPP, low-substituted hydroxypropyl cellulose, flavouring protein sugar, lubricant polyethylene glycol 4000, polyvinyl pyrrolidone K30 are crushed, and cross 80~100 mesh sieves, standby;Then compound ginseng stilbene dry extract and hardship are taken Join plain powder, add premix, the premix of disintegrant of diluent, mix, added dissolved with protein sugar powder in container The ethanol solution of 10% PVP K30, softwood processed, softwood are pelletized with 24 mesh sieves, and wet granular is dried under the conditions of 60 DEG C Dry, prepare the dry particl of compound ginseng stilbene dispersible tablet.
Preferably, in the preparation method of compound ginseng stilbene dispersible tablet of the present invention, the step 2)In prepare it is dilute during particle It is respectively 2 according to mass ratio that the premix of agent, which is released, as pregelatinized starch, microcrystalline cellulose, lactose powder:1:1,2:2:1 and 2:1: 2 mixture;The premix of disintegrant is PVPP, low-substituted hydroxypropyl cellulose powder according to quality score Wei 1:1,1:2 and 2:1 mixture;Adhesive is molten for the ethanol of 10% PVP K30 dissolved with protein sugar powder Liquid.
Preferably, in the preparation method of compound ginseng stilbene dispersible tablet of the present invention, the step 2)In prepare it is dilute during particle The dosage of agent premix is released, with 1000 for radix, its dosage is 165~172g;The dosage of disintegrant premix, with 1000 For radix, its dosage is 30g.
Preferably, in the preparation method of compound ginseng stilbene dispersible tablet of the present invention, the step 3)Middle mixed process is as follows: It is standby with 24 mesh sieve whole grains by dried particle;It is 2 in mass ratio by Macrogol 4000 powder and superfine silica gel powder powder:1 It is well mixed, the premix of lubricant is prepared, it is standby;Disintegrant premix 20g and 6g lubricant premix is used into equivalent again Mixing method of progressively increasing is well mixed;Finally above-mentioned powder and the particle after whole grain are well mixed using equivalent mixing method of progressively increasing again, Tabletting, produce compound ginseng stilbene dispersible tablet.
Compared with prior art, the present invention has advantages below to the present invention:The present invention creatively makes in extraction step Method by the use of Stepanol MG as surfactant assisted extraction;The present invention creatively prepare compound ginseng stilbene disperse Premix during piece from pregelatinized starch, three kinds of microcrystalline cellulose, lactose auxiliary materials is diluent;The present invention is creatively making It is for premix during compound ginseng stilbene dispersible tablet from two kinds of PVPP, low-substituted hydroxypropyl cellulose auxiliary materials Disintegrant;The present invention is creatively when preparing compound ginseng stilbene dispersible tablet from the premix of Macrogol 4000 and superfine silica gel powder Powder is lubricant;The present invention has creatively dissolved in flavouring albumen Icing Sugar in the ethanol solution of adhesive PVP K30 End.And obtain compound ginseng stilbene dispersible tablet in good taste, that disintegration is rapid, easy to carry.
Embodiment
A kind of preparation method of compound ginseng stilbene dispersible tablet is provided in embodiments of the invention, is comprised the following steps:
1)To ginseng, the Radix Astragali, cassia seed, prepared rhizome of rehmannia, rhizoma Gastrodiae, the taste Chinese medicine of rhizoma alismatis 6 in the presence of surfactants through water extracting alcohol It is heavy to obtain extraction immersion liquid, obtain compound ginseng stilbene dry extract powder by being dried in vacuo;
2)Stilbene dry extract powder and kushenin powder are joined as raw material using compound, add the premix of diluent, partial disintegration agent Premix, pelletized by adhesive of the ethanol solution of PVP K30;
3)The dry particl of compound ginseng stilbene dispersible tablet is well mixed with partial disintegration agent premix and lubricant premix, tabletting, Prepare compound ginseng stilbene dispersible tablet.
Preferably, in the preparation method of compound ginseng stilbene dispersible tablet of the present invention, the step 1)In 6 taste Chinese medicines carry Take, carry out by the following method:Weigh ginseng 380g, Radix Astragali 310g, cassia seed 180g, prepared rhizome of rehmannia 180g, rhizoma Gastrodiae 90g, rhizoma alismatis 130g is placed in extractor, is added 3.81g Stepanol MGs and is added 12.7L water, heating and refluxing extraction 2h, filtering, Filtrate is standby;Residue adds 12.7L water refluxing extraction 2h, filtering, merges 2 filtrates, under the conditions of 60~65 DEG C, filtrate subtracts Pressure is concentrated into the clear cream that relative density is 1.20~1.25, adds ethanol alcohol content is stood 24h, filtering, filtrate decompression up to 70% Concentration and recovery ethanol, under the conditions of 60~65 DEG C, the clear cream that relative density is 1.20~1.25 is concentrated into, be dried in vacuo into dry Medicinal extract, above-mentioned dry extract is crushed, cross 80~100 mesh sieves, obtain compound ginseng stilbene dry extract powder;It is highly preferred that surface-active The dosage of agent Stepanol MG is the 0.3% of 6 taste Chinese medicine gross masses.
Preferably, in the preparation method of compound ginseng stilbene dispersible tablet of the present invention, the step 2)Middle compound ginseng stilbene disperses The method of granulating of piece is wet granulation.
It is highly preferred that the step 2)Middle pelletization is as follows:By kushenin, diluents microcrystalline cellulose, pregelatinated form sediment Powder, lactose, disintegrant PVPP, low-substituted hydroxypropyl cellulose, flavouring protein sugar, lubricant polyethylene glycol 4000, polyvinyl pyrrolidone K30 are crushed, and cross 80~100 mesh sieves, standby;Then compound ginseng stilbene dry extract and hardship are taken Join plain powder, add premix, the premix of disintegrant of diluent, mix, added dissolved with protein sugar powder in container The ethanol solution of 10% PVP K30, softwood processed, softwood are pelletized with 24 mesh sieves, and wet granular dries under the conditions of 60 DEG C It is dry, prepare the dry particl of compound ginseng stilbene dispersible tablet.
Preferably, in the preparation method of compound ginseng stilbene dispersible tablet of the present invention, the step 2)In prepare it is dilute during particle It is respectively 2 according to mass ratio that the premix of agent, which is released, as pregelatinized starch, microcrystalline cellulose, lactose powder:1:1,2:2:1 and 2:1: 2 mixture;The premix of disintegrant is PVPP, low-substituted hydroxypropyl cellulose powder according to quality score Wei 1:1,1:2 and 2:1 mixture;Adhesive is molten for the ethanol of 10% PVP K30 dissolved with protein sugar powder Liquid.
Preferably, in the preparation method of compound ginseng stilbene dispersible tablet of the present invention, the step 2)In prepare it is dilute during particle The dosage of agent premix is released, with 1000 for radix, its dosage is 165~172g;The dosage of disintegrant premix, with 1000 For radix, its dosage is 30g.
Preferably, in the preparation method of compound ginseng stilbene dispersible tablet of the present invention, the step 3)Middle mixed process is as follows: It is standby with 24 mesh sieve whole grains by dried particle;It is 2 in mass ratio by Macrogol 4000 powder and superfine silica gel powder powder:1 It is well mixed, the premix of lubricant is prepared, it is standby;Disintegrant premix 20g and 6g lubricant premix is used into equivalent again Mixing method of progressively increasing is well mixed;Finally above-mentioned powder and the particle after whole grain are well mixed using equivalent mixing method of progressively increasing again, Tabletting, produce compound ginseng stilbene dispersible tablet.
Below in conjunction with the embodiment in the present invention, the technical scheme in the present invention is clearly and completely described.It is aobvious So, described embodiment is only part of the embodiment of the present invention, rather than whole embodiments.Based on the reality in the present invention Example is applied, the every other embodiment that those of ordinary skill in the art are obtained under the premise of creative work is not made, is all belonged to In the scope of protection of the invention.
Embodiment 1:Compound joins the preparation of stilbene dispersible tablet
1st, the preparation process of compound ginseng stilbene dry extract:Weigh ginseng 380g, Radix Astragali 310g, cassia seed 180g, prepared rhizome of rehmannia 180g, day Numb 90g, rhizoma alismatis 130g are placed in extractor, are added 3.81g Stepanol MGs and are added 12.7L water, are heated to reflux carrying 2h is taken, is filtered, filtrate is standby;Residue adds 12.7L water refluxing extraction 2h, filtering, merges 2 filtrates, in 60~65 DEG C of bars Under part, filtrate decompression is concentrated into the clear cream that relative density is 1.20~1.25, adds ethanol alcohol content is stood 24h, mistake up to 70% Filter, filtrate decompression concentration and recovery ethanol, under the conditions of 60~65 DEG C, the clear cream that relative density is 1.20~1.25 is concentrated into, very Sky is dried to dry extract, and above-mentioned dry extract is crushed, and crosses 80~100 mesh sieves, standby, obtains compound ginseng stilbene dry extract powder, its Quality is 132g;
2nd, by kushenin, diluents microcrystalline cellulose, pregelatinized starch, lactose, disintegrant PVPP, low take Crushed for hydroxypropylcellulose, flavouring protein sugar, lubricant Macrogol 4000, polyvinyl pyrrolidone K30, cross 80 ~100 mesh sieves, it is standby;
3rd, it is 2 according to mass ratio by the microcrystalline cellulose, pregelatinized starch, lactose powder of crossing 80~100 mesh sieves:1:2 mixing are equal It is even, prepare the premix of diluent;PVPP, the low-substituted hydroxypropyl cellulose powder of 80~100 mesh sieves will be crossed End is 2 according to weight ratio:1 is well mixed, prepares the premix of disintegrant;By recipe quantity, every 1000 are radix, take step 1 Compound ginseng stilbene dry extract powder 132g and kushenin powder 50g, the premix 168g of diluent, the premix 30g of disintegrant, will Above-mentioned material mixes in mixer, adds the ethanol solution of 10% PVP K30 dissolved with protein sugar powder, uses High-speed granulator or oscillating granulator softwood, softwood are pelletized with 24 mesh sieves, and wet granular dries drying under the conditions of 60 DEG C;
4th, it is standby with 24 mesh sieve whole grains after wet granular is dried;By Macrogol 4000 powder and superfine silica gel powder powder in mass ratio For 2:1 is well mixed, prepares the premix of lubricant, standby;The premix of disintegrant premix 20g and 6g lubricant is used again Equivalent mixing method of progressively increasing is well mixed;Finally above-mentioned powder and the particle after whole grain are mixed using equivalent mixing method of progressively increasing again It is even, tabletting, compound ginseng stilbene dispersible tablet is produced, the dispersible tablet is checked according to the disintegration time limited inspection technique of 2015 editions Chinese Pharmacopoeias one Disintegration time limited be 2.2min.

Claims (9)

1. a kind of preparation method of compound ginseng stilbene dispersible tablet, comprises the following steps:
1)To ginseng, the Radix Astragali, cassia seed, prepared rhizome of rehmannia, rhizoma Gastrodiae, the taste Chinese medicine of rhizoma alismatis 6 in the presence of surfactants through water extracting alcohol It is heavy to obtain extraction immersion liquid, obtain compound ginseng stilbene dry extract powder by being dried in vacuo;
2)Stilbene dry extract powder and kushenin powder are joined as raw material using compound, add the premix of diluent, partial disintegration agent Premix, pelletized by adhesive of the ethanol solution of PVP K30;
3)The dry particl of compound ginseng stilbene dispersible tablet is well mixed with partial disintegration agent premix and lubricant premix, tabletting, Prepare compound ginseng stilbene dispersible tablet.
2. according to the method for claim 1, it is characterised in that the step 1)In 6 taste Chinese medicines extraction, by following Method is carried out:Weigh ginseng 380g, Radix Astragali 310g, cassia seed 180g, prepared rhizome of rehmannia 180g, rhizoma Gastrodiae 90g, rhizoma alismatis 130g and be placed in extraction In device, add 3.81g surfactants and add the Extraction solvent of 10 times of crude drug amounts, extract 2 times, 2 hours every time, filter, close And filtrate, filtrate decompression are concentrated into relative density as 1.20~1.25(60~65 DEG C)Clear cream, add ethanol to reach alcohol content 70%, 24 hours are stood, filtering, filtrate decompression concentration and recovery ethanol, it is 1.20~1.25 to be concentrated into relative density(60~65 ℃)Clear cream, be dried in vacuo into dry extract, above-mentioned dry extract crushed, cross 80~100 mesh sieves, it is standby, obtain compound ginseng stilbene do Medicinal extract powder.
3. according to the method for claim 2, it is characterised in that the Extraction solvent is water, and refluxing extraction number is 2 times, Each extraction time is respectively 2,2 hours, and adds surfactant sodium dodecyl base magnesium sulfate when extracting for the 1st time.
4. according to the method for claim 3, it is characterised in that the addition of the surfactant sodium dodecyl base magnesium sulfate For the 0.3% of 6 taste Chinese medicine gross masses.
5. according to the method for claim 1, it is characterised in that the step 2)The method of granulating of middle compound ginseng stilbene dispersible tablet For wet granulation.
6. according to the method for claim 5, it is characterised in that the step 2)Middle wet granulation, enters by the following method OK:By kushenin, diluents microcrystalline cellulose, pregelatinized starch, lactose, disintegrant PVPP, low substitution Hydroxypropylcellulose, flavouring protein sugar, lubricant Macrogol 4000, polyvinyl pyrrolidone K30 are crushed, excessively 80~ 100 mesh sieves, it is standby;Then compound ginseng stilbene dry extract and kushenin powder are taken, adds premix, the premix of disintegrant of diluent Material, mixes in container, adds the ethanol solution of 10% PVP K30 dissolved with protein sugar powder, softwood processed is soft The mesh sieve of timber-used 24 is pelletized, and wet granular dries drying under the conditions of 60 DEG C, prepares the dry particl of compound ginseng stilbene dispersible tablet.
7. according to the method for claim 6, it is characterised in that the step 2)The premix of middle diluent when preparing particle According to mass ratio it is respectively 2 for pregelatinized starch, microcrystalline cellulose, lactose powder:1:1,2:2:1 and 2:1:2 mixture;Collapse The premix for solving agent is PVPP, low-substituted hydroxypropyl cellulose powder according to mass ratio is respectively 1:1,1:2 And 2:1 mixture;Adhesive is the ethanol solution dissolved with 10% PVP K30 of protein sugar powder.
8. according to the method for claim 7, it is characterised in that the step 2)Middle diluent premix when preparing particle Dosage, with 1000 for radix, its dosage is 165~172g;The dosage of disintegrant premix, with 1000 for radix, it is used Measure as 30g.
9. according to the method for claim 1, it is characterised in that the step 3)Middle mixed process is as follows:Will be dried Particle, it is standby with 24 mesh sieve whole grains;It is 2 in mass ratio by Macrogol 4000 powder and superfine silica gel powder powder:1 is well mixed, The premix of lubricant is prepared, it is standby;Disintegrant premix 20g and 6g lubricant premix is progressively increased mixing method using equivalent again It is well mixed;Finally above-mentioned powder and the particle after whole grain are well mixed using equivalent mixing method of progressively increasing again, tabletting, produces and answers Side's ginseng stilbene dispersible tablet.
CN201710944041.XA 2017-10-12 2017-10-12 A kind of preparation method of compound ginseng stilbene dispersible tablet Pending CN107625894A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710944041.XA CN107625894A (en) 2017-10-12 2017-10-12 A kind of preparation method of compound ginseng stilbene dispersible tablet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710944041.XA CN107625894A (en) 2017-10-12 2017-10-12 A kind of preparation method of compound ginseng stilbene dispersible tablet

Publications (1)

Publication Number Publication Date
CN107625894A true CN107625894A (en) 2018-01-26

Family

ID=61103967

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710944041.XA Pending CN107625894A (en) 2017-10-12 2017-10-12 A kind of preparation method of compound ginseng stilbene dispersible tablet

Country Status (1)

Country Link
CN (1) CN107625894A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109393468A (en) * 2018-12-13 2019-03-01 江苏省农业科学院 A kind of preparation method of radix cynanchi bungei pueraria lobata oral buccal tablet

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101269113A (en) * 2008-05-09 2008-09-24 李彦群 Quality control method for medicament composition for treating knubble

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101269113A (en) * 2008-05-09 2008-09-24 李彦群 Quality control method for medicament composition for treating knubble

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
凌汶静: "常用抗肿瘤中药的临场应用与规律探讨", 《医药卫生科技辑》 *
金凌洁等: "表面活性剂增效墨旱莲总黄酮水提工艺的研究", 《机电信息》 *
高静: "《物理化学》", 31 January 2016, 中国医药科技出版社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109393468A (en) * 2018-12-13 2019-03-01 江苏省农业科学院 A kind of preparation method of radix cynanchi bungei pueraria lobata oral buccal tablet

Similar Documents

Publication Publication Date Title
CN103251856B (en) Traditional Chinese medicine preparation for benefiting Qi and nourishing blood and preparation method of traditional Chinese medicine preparation
CN101612357A (en) A kind of Chinese medicine composition for the treatment of tumor and preparation method thereof
CN102579669A (en) Chinese medicinal composition for nourishing qi and blood and conditioning menstruation and preparation method thereof
CN103223104B (en) A kind of Chinese medicine composition treating diabetes and preparation method thereof
CN102319357B (en) Lipid-lowering dispersible tablets and preparation technology thereof
CN1330345C (en) Combination of Chinese traditional medicine for treating hyperlipemia, and preparation method
CN1318058C (en) Method for preparing concentrated pill for treating mammary gland proliferation disease
CN107625894A (en) A kind of preparation method of compound ginseng stilbene dispersible tablet
CN107033001A (en) A kind of Chlorogenic acid compound and the compound stranguria-treating and calculus-removing tablet containing the compound
CN104027607B (en) A kind of Chinese herbal granules preparation technology for treating hypertension
CN102940750B (en) Medicine composition for treating gout
CN108619314A (en) A kind of preparation method of Chinese medicinal granule object
CN100534466C (en) Preparation for treating arthritis and preparation method thereof
CN107617031A (en) A kind of preparation method of compound stalk ginseng lozenge
CN103494916B (en) Traditional Chinese medicine composition with effect of reducing blood sugar, as well as preparation method and application thereof
CN103494894B (en) A kind of have Chinese medicine composition reducing blood glucose effect and its preparation method and application
CN102940747B (en) Medicine composition for treating gout
CN1250273C (en) Venom capsule for treating brain cancer
CN100484550C (en) Chinese patent medicine for treating leukopenia due to tumor treating radiotherapy and chemotherapy, and preparation method thereof
CN100482267C (en) Preparation for diabetes and its making method
CN102085318B (en) Coix seed/ginseng buccal tablet and preparation method thereof
CN108815448A (en) A kind of Chinese herbal granules for treating chronic colitis
CN104784244B (en) A kind of compound Chinese medicinal preparation for treating tumour
CN113694039B (en) Pellet for tonifying qi and benefiting blood and preparation method thereof
CN115364179B (en) Traditional Chinese medicine composition for reducing blood uric acid as well as preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20180126

WD01 Invention patent application deemed withdrawn after publication